Join the DDA or

Xarelto recall

Rogue blister strip

September 29th 2017

Tagged: MHRA alert

By Ailsa Colquhoun

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 (action in 48 hours) alert for one batch of Xarelto (rivaroxaban) 20mg film-coated tablets pack size 1 x 28 (Strathclyde Pharmaceuticals Ltd).

The affected batch is: BXHHDR1

Strathclyde Pharmaceuticals Ltd has received a report of a rogue blister strip of 15mg tablets within two packs of 20mg tablets and has decided to recall this batch. The labelling on one side of the blister strips reflects the correct strength of the tablets (a photo can be seen on the alert).

For all the latest news of the 2018 DDA annual conference...

Learn more